Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1F 18 T807----[1] 127
2F-18----[2] 5, 127
3F-18 3F4AP----[1] 13
4F-18 AV 1451----[1] 5
5F-18 FDG----[1] 127
6F-18 FEDAA1106 (BAY85-8101)----[1] 13
7F-18 FPCIT----[1] 6
8F-A-F-A (FIASP-NovoRapid-FIASP-NovoRapid)----[1] 299
9F13CD----[1] 288
10F8IL10----[2] 46, 97
11F8VR----[1] 288
12FAB122----[1] 2
13FABRAZYME[1] Agalsidase beta[1] D03228 [1] GLA 💬[6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬[1] 19
14Fabrazyme (agalsidase beta)[1] Agalsidase beta[1] D03228 [1] GLA 💬[6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬[1] 19
15FABRAZYME - 35 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE ENDOVENOSA 1 FLACONCINO[1] Agalsidase beta[1] D03228 [1] GLA 💬[6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬[1] 19
16Fabrazyme 35 mg[1] Agalsidase beta[1] D03228 [1] GLA 💬[6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬[1] 19
17Fabrazyme 5 mg[1] Agalsidase beta[1] D03228 [1] GLA 💬[6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬[1] 19
18FACTANE 200 IU/ml----[1] 288
19Factor VIII[1] Beroctocog alfa---[1] 288
20Factor VIII concentrate[1] Beroctocog alfa---[1] 288
21Factor von Willebrand[1] Von Willebrand factor human---[1] 288
22FACTOR X[1] Coagulation factor X human---[1] 288
23Factor XIII[1] Factor XIII (human)---[3] 51, 97, 288
24Factor XIII Concentrate (Human)[1] Factor XIII (human)---[1] 288
25Factor XIII Concentrate (Human), Pasteurized[1] Factor XIII (human)---[1] 288
26Faecal matter----[1] 97
27Faecal Microbiota Transplant----[1] 97
28Faecal microbiota transplantation----[5] 46, 84, 96, 97, 271
29Faecal sampling----[1] 46
30FAM Therapy----[1] 228
31FamC-1----[1] 2
32Famciclovir[1] Famciclovir[1] D00317 --[1] 13
33FAMOTIDINA[1] Famotidine[1] D00318 [1] HRH2 💬[3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬[1] 61
34Famotidine[1] Famotidine[1] D00318 [1] HRH2 💬[3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬[6] 6, 46, 86, 98, 107, 300
35Famotidine 20 MG[1] Famotidine[1] D00318 [1] HRH2 💬[3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬[1] 86
36FAMPRIDINA[1] Dalfampridine[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13
37FAMPRIDINE[1] Dalfampridine[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[2] 13, 14
38Fampridine SR[1] Dalfampridine[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13
39Fampridine-SR[1] Dalfampridine[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13
40Fampridine-SR b.i.d. (Twice Daily)[1] Dalfampridine[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13
41FAMPYRA[1] Dalfampridine[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[2] 13, 14
42FAMPYRA - 10 MG - COMPRESSA A RILASCIO PROLUNGATO - USO ORALE - FLACONE (HDPE) 56 COMPRESSE (4 FLACONI DA 14)[1] Dalfampridine[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13
43Fampyra 10 mg prolonged-release tablets[2] Dalfampridine,
Manganese citrate		[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13
44Fampyra 10mg prolonged release tablets[2] Dalfampridine,
Manganese citrate		[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13
45Fan beam CT scan----[1] 49
46Fang yi qing feng shi granule----[1] 46
47FANG(30)----[1] 46
48Fanhdi----[1] 288
49FANHDI 100 UI----[1] 288
50Fanhdi 100 UI FVIII-120 UI FVW----[1] 288
51FANHDI 25 UI----[1] 288
52Fanhdi 25 UI FVIII-30 UI FVW----[1] 288
53FANHDI 250UI*1F 250UI+F 10ML----[1] 288
54FANHDI 50 UI----[1] 288
55Fanhdi 50 UI FVIII-60 UI FVW----[1] 288
56FANHDI*INF FL 250UI+SIR SOLV+S----[1] 288
57FANHDI*INF FL 500UI+SIR SOLV+S----[1] 288
58FANHDI*INF FL1000UI+SIR SOLV+S----[1] 288
59FANHDI*INF FL250UI+SIR SOLV+S----[1] 288
60Fansidar (pyrimethamine and sulfadoxine)[2] Pyrimethamine,
Sulfadoxine		[2] D00488 ,
D00580 		--[1] 65
61Fasenra[1] Benralizumab[1] D09874 [1] IL5RA 💬[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[5] 44, 45, 98, 162, 299
62Faslodex[1] Fulvestrant[1] D01161 [2] ESR1,
ESR2 💬		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 49
63Fasudil[1] Fasudil[1] D07941 [2] ROCK1,
ROCK2 💬		[23] Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 2, 5, 7, 51
64Fasudil (WP-0512)[1] Fasudil[1] D07941 [2] ROCK1,
ROCK2 💬		[23] Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2
65FASUDIL HYDROCHLORIDE[1] Fasudil[1] D07941 [2] ROCK1,
ROCK2 💬		[23] Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2
66Fat diet----[1] 78
67Fatigue----[1] 13
68FAXE Kondi----[1] 257
69Faxe Kondi Free----[1] 257
70FB-101----[1] 6
71FB704A----[1] 46
72FBL-MTX----[1] 46
73FBS0701----[1] 284
74FBS0701 CAPSULE----[1] 284
75FBS0701/SSP004184----[1] 284
76FBX-101----[1] 19
77Fc- and CDR-modified humanised monoclonal antibody against C5----[3] 11, 62, 109
78FCM----[2] 63, 222
79FCN-159----[1] 34
80FCR001----[1] 51
81FCX-007 (dabocemagene autoficel----[1] 36
82FDC macitentan/tadalafil[2] Macitentan,
Tadalafil		[2] D02008 ,
D10135 		[3] EDNRA,
EDNRB,
PDE5A 💬		[11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86
83FDG----[1] 84
84FDG-PET----[1] 299
85FDL169----[1] 299
86FDL176----[1] 299
87FDL176 & FDL169 coadministration----[1] 299
88FE 992097----[1] 193
89FE 999301----[2] 96, 97
90Feburane----[1] 21
91Febuxostat[1] Febuxostat[1] D01206 [1] XDH 💬[5] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬[3] 2, 6, 13
92Fecal Microbial transplant----[2] 96, 97
93Fecal microbial transplant (FMT)----[1] 13
94Fecal Microbial Transplantation----[2] 96, 97
95Fecal Microbial Transplants----[1] 13
96Fecal microbiota----[3] 13, 96, 97
97Fecal microbiota capsule----[1] 97
98Fecal Microbiota Enema----[1] 97
99Fecal Microbiota Transplant----[2] 96, 97
100Fecal Microbiota Transplant (FMT)----[2] 96, 97
101Fecal microbiota transplantation----[5] 2, 66, 94, 96, 97
102Fecal Microbiota Transplantation (FMT)----[2] 96, 97
103Fecal Microbiota Transplantation (FMT) of FMP30 Donor Stool----[1] 13
104Fecal Microbiota Transplantation (FMT), OpenBiome----[1] 97
105Felzartamab[1] Felzartamab---[1] 66
106Femoston 1/10----[1] 13
107Femoston 2/10----[1] 13
108Fendrix[1] Hepatitis B Vaccine (Recombinant)---[1] 46
109Fendrix suspension for injection[1] Hepatitis B Vaccine (Recombinant)---[1] 46
110Fendrix suspension for injection Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed).[1] Hepatitis B Vaccine (Recombinant)---[1] 46
111FENEBRUTINIB[1] Fenebrutinib[1] D11457 [1] BTK 💬[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 13
112Fenfluramina[1] Fenfluramine[1] D07945 [4] HTR2A,
HTR2B,
HTR2C,
SLC6A4 💬		[6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[2] 140, 144
113Fenfluramina Cloridrato[1] Fenfluramine[1] D07945 [4] HTR2A,
HTR2B,
HTR2C,
SLC6A4 💬		[6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[2] 140, 144
114FENFLURAMINE[1] Fenfluramine[1] D07945 [4] HTR2A,
HTR2B,
HTR2C,
SLC6A4 💬		[6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[4] 140, 144, 145, 149
115Fenfluramine HCl, DL-Fenfluramine, (±)-Fenfluramine[1] Fenfluramine[1] D07945 [4] HTR2A,
HTR2B,
HTR2C,
SLC6A4 💬		[6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 144
116FENFLURAMINE HYDROCHLORIDE[1] Fenfluramine[1] D07945 [4] HTR2A,
HTR2B,
HTR2C,
SLC6A4 💬		[6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[2] 140, 144
117FENFLURAMINE HYDROCHLORIDE (colorless)[1] Fenfluramine[1] D07945 [4] HTR2A,
HTR2B,
HTR2C,
SLC6A4 💬		[6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[2] 140, 144
118FENFLURAMINE HYDROCHLORIDE (red)[1] Fenfluramine[1] D07945 [4] HTR2A,
HTR2B,
HTR2C,
SLC6A4 💬		[6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 140
119Fengshigutong Capsule----[1] 271
120Fengshigutong Capsule plus Imrecoxib[1] Imrecoxib---[1] 271
121Fenilbutirato----[1] 2
122Fenofibrate[1] Fenofibrate[1] D00565 [1] PPARA 💬[10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[5] 8, 79, 93, 94, 265
123Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle)[1] Fenofibrate[1] D00565 [1] PPARA 💬[10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93
124Fenretinide[1] Fenretinide[1] D04162 [2] RARA,
RARB 💬		[8] Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬[1] 299
125Fentanyl[1] Fentanyl[2] D00320 ,
D01399 		[1] OPRM1 💬[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬[4] 46, 70, 215, 231
126Fentanyl (High Dose)[1] Fentanyl[2] D00320 ,
D01399 		[1] OPRM1 💬[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬[1] 215
127Fentanyl (Low Dose)[1] Fentanyl[2] D00320 ,
D01399 		[1] OPRM1 💬[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬[1] 215
128Fentanyl (Low Dose) + Dexmedetomidine[2] Dexmedetomidine,
Fentanyl		[4] D00320 ,
D00514 ,
D01205 ,
D01399 		[4] ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬		[4] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 215
129Fentanyl transdermal patch[1] Fentanyl[2] D00320 ,
D01399 		[1] OPRM1 💬[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬[1] 46
130Feraheme[1] Ferumoxytol[1] D04177 --[1] 13
131Ferinject----[2] 86, 299
132Ferinject or CosmoFer----[1] 86
133Fermented oyster extract[1] Oyster---[1] 84
134Ferric Carboxy Maltose[1] Maltose[1] D00044 --[1] 96
135FERRIC CARBOXYMALTOSE[1] Ferric carboxymaltose[1] D08920 --[4] 86, 96, 97, 299
136Ferric Maltol[1] Ferric maltol[1] D10833 --[1] 96
137Ferricarboxymaltose----[1] 86
138Ferriprox[1] Deferiprone[1] D07416 --[2] 6, 120
139Ferriprox 500 mg[1] Deferiprone[1] D07416 --[1] 6
140FERRIPROX*100CPR RIV 500MG[1] Deferiprone[1] D07416 --[1] 120
141Ferrograd----[1] 46
142Ferrograd Folic Tablets----[1] 46
143Ferrous sulfate 325mg[1] Sulfate ion---[1] 299
144Ferrous sulphate----[2] 96, 97
145Ferrous sulphate 200mg oral tablet----[1] 227
146Ferrprox (Deferiprone)[1] Deferiprone[1] D07416 --[1] 6
147Ferulic acid[1] Ferulic acid---[1] 127
148Ferumoxytol[1] Ferumoxytol[1] D04177 --[1] 13
149Fesoterodine[1] Fesoterodine[1] D07226 [2] CHRM2,
CHRM3 💬		[13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 6
150Fetal porcine cells, Neurocell-PD----[1] 6
151Fetal surgery for MMC repair----[1] 118
152Fexinidazole[1] Fexinidazole[1] D11252 --[1] 65
153Fexofenadine[1] Fexofenadine[2] D00671 ,
D07958 		[1] HRH1 💬[3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬[2] 13, 46
154FFP104----[2] 93, 96
155FG-3019----[3] 85, 113, 222
156FG-3019 10mg/mL in 10 mL vials----[1] 85
157Fibrate treatment----[1] 160
158Fibrin[1] Fibrin---[1] 96
159Fibrin glue injection in fistula[1] Fibrin---[1] 96
160Fibrinogen[1] Fibrinogen human---[3] 14, 65, 288
161Fibrinogen (coagulation factorI)[1] Fibrinogen human---[1] 65
162Fibrinogen concentrate[1] Fibrinogen human---[1] 14
163Fibrinogen Concentrate from Human Plasma[1] Fibrinogen human---[1] 65
164Fibroblasts----[1] 36
165Fibrogammin P----[1] 288
166Fibrogammin® 1250----[1] 51
167Fibrogammin® P----[1] 288
168Fibrogammin®P----[1] 288
169Fibrogammin®P, coagulation factor XIII concentrate (Human)[1] Factor XIII (human)---[1] 51
170Fibroscan----[2] 93, 171
171Fibrovein----[1] 279
172Fibrovein 3%----[1] 279
173Fig[1] Fig---[1] 2
174Filamentous haemagglutinin[1] Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)---[1] 46
175Filamentous haemagglutinin adsorbed[1] Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)---[1] 46
176FILGOTINIB[1] Filgotinib[1] D10871 [1] JAK1 💬[27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[6] 46, 53, 96, 97, 222, 271
177Filgotinib 200mg/day[1] Filgotinib[1] D10871 [1] JAK1 💬[27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46
178Filgrastim[1] Filgrastim[1] D03235 [1] CSF3R 💬[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[28] 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331
179Filgrastim (G-CSF)[1] Filgrastim[1] D03235 [1] CSF3R 💬[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 331
180Filgrastim Hexal[1] Filgrastim[1] D03235 [1] CSF3R 💬[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 65
181Filgrastim, Alemtuzumab[2] Alemtuzumab,
Filgrastim		[2] D02802 ,
D03235 		[2] CD52,
CSF3R 💬		[6] , Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 65
182Film-coated tablet----[1] 97
183Finamine tablets----[1] 6
184Finasteride[1] Finasteride[1] D00321 [1] SRD5A2 💬[3] Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬[1] 6
185Finely ground flaxseed powder[1] Flax seed---[1] 299
186Fingolimob----[1] 13
187Fingolimob (FTY)----[1] 13
188FINGOLIMOD[1] Fingolimod[1] D10001 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[3] 13, 14, 156
189Fingolimod (FTY720)[1] Fingolimod[1] D10001 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 156
190Fingolimod 0.5 mg[1] Fingolimod[1] D10001 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13
191Fingolimod 0.5mg[1] Fingolimod[1] D10001 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13
192Fingolimod 1.25 mg[1] Fingolimod[1] D10001 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13
193FINGOLIMOD HYDROCHLORIDE[1] Fingolimod[1] D10001 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 14
194Fingolimodi----[1] 13
195Fingolmod----[1] 13
196Fipamezole[1] Fipamezole---[2] 6, 17
197Fipamezole hydrochloride[1] Fipamezole---[2] 6, 17
198Fipamezole hydrochloride 30 mg oral disintegrating tablets[1] Fipamezole---[2] 6, 17
199Fipamezole hydrochloride 60 mg oral disintegrating tablets[1] Fipamezole---[2] 6, 17
200Fipamezole hydrochloride 90 mg oral disintegrating tablets[1] Fipamezole---[2] 6, 17
201Fipamezole ODT[1] Fipamezole---[1] 6
202Fipamezole ODT Cohort 2[1] Fipamezole---[1] 6
203Firategrast[1] Firategrast[1] D06590 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
204Firategrast (USAN approved name)[1] Firategrast[1] D06590 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
205Firategrast 150 mg[1] Firategrast[1] D06590 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
206Firategrast 300 mg[1] Firategrast[1] D06590 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
207Firategrast gastro-retentive solution[1] Firategrast[1] D06590 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
208Firategrast immediate release tablet[1] Firategrast[1] D06590 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
209Firategrast modified release tablet[1] Firategrast[1] D06590 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
210Firdapse[1] Amifampridine[1] D10228 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[2] 3, 11
211FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE[1] Amifampridine[1] D10228 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[2] 3, 11
212First line DMT----[1] 13
213Fish Oil[1] Fish oil---[7] 13, 46, 49, 66, 96, 260, 299
214Fish oil concentrate[1] Fish oil---[1] 13
215Fish oil supplement[1] Fish oil---[1] 46
216Fish oil, gamma-linolenic acid[3] Fish oil,
Gamolenic acid,
alpha-Linolenic acid		[1] D07213 --[1] 46
217FISH OIL, RICH IN OMEGA-3-ACIDS[2] Fish oil,
Omega-3 fatty acids		---[1] 13
218FISH OIL,RICH IN OMEGA 3 ACIDS[1] Fish oil---[1] 13
219FITC-Adalimumab[1] Adalimumab[1] D02597 [1] TNF 💬[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[2] 96, 97
220Fixed dose combination Ciprofloxacin/Celecoxib[2] Celecoxib,
Ciprofloxacin		[3] D00186 ,
D00567 ,
D02216 		[1] PTGS2 💬[22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 2
221FK-506----[1] 60
222FK506----[1] 222
223FK506 level 2-3 ng/ml----[1] 86
224FK506 level 3-5 ng/ml----[1] 86
225FK506 level < 2 ng/ml----[1] 86
226FKB327----[1] 46
227FKB327 AI----[1] 46
228FKB327 PFS----[1] 46
229Flagyl[1] Metronidazole[3] D00409 ,
D05016 ,
D05017 		--[2] 96, 97
230Flash glucose monitoring system[1] Dextrose, unspecified form---[1] 49
231Flavocoxid----[1] 113
232Flavoxate[1] Flavoxate[2] D00718 ,
D07961 		[16] PDE10A,
PDE11A,
PDE1A,
PDE1B,
PDE1C,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE7A,
PDE7B,
PDE8A,
PDE8B 💬		[18] Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
233Flaxseed[1] Flax seed---[2] 97, 299
234Flaxseed lignan-enriched complex (FLC)[1] Flax seed---[1] 97
235FLEBOGAMMA 5%----[1] 15
236Flebogamma 5% DIF----[1] 65
237Flecainide[1] Flecainide[2] D00638 ,
D07962 		[5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 6
238FLECAINIDE ACETATE[2] Acetate,
Flecainide		[2] D00638 ,
D07962 		[5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 6
239Flecainidum[1] Flecainide[2] D00638 ,
D07962 		[5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 6
240Flexible bronchoscopy in moderate sedation----[1] 84
241Flixabi[1] Infliximab[1] D02598 [1] TNF 💬[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[2] 96, 97
242Flolan[1] Epoprostenol[2] D00106 ,
D01337 		[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
243FLOLAN injection with currently marketed diluent[1] Epoprostenol[2] D00106 ,
D01337 		[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
244FLOLAN injection with reformulated diluent[1] Epoprostenol[2] D00106 ,
D01337 		[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
245FLOLAN TM and Glycine Diluent[2] Epoprostenol,
Glycine		[3] D00011 ,
D00106 ,
D01337 		[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
246Flolan®[1] Epoprostenol[2] D00106 ,
D01337 		[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
247FLOLAN™ and Glycine Diluent[2] Epoprostenol,
Glycine		[3] D00011 ,
D00106 ,
D01337 		[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
248FLORBETABEN (18F)[1] Florbetaben (18F)---[1] 6
249Florbetapir (18F)[1] Florbetapir (18F)---[1] 127
250Florbetapir 18F----[1] 127
251Florbetapir 18F Injection----[1] 127
252Florbetapir F 18----[1] 6
253Florence 30 µg/mL----[1] 98
254Florence 60 µg/mL----[1] 98
255Florence 90 µg/mL----[1] 98
256Flortaucipir[1] Flortaucipir[1] D11210 [1] MAPT 💬[4] Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬[3] 5, 7, 127
257Flortaucipir F18[1] Flortaucipir[1] D11210 [1] MAPT 💬[4] Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬[3] 5, 7, 127
258Floseal----[1] 227
259Flovent----[1] 98
260Flow-mediated dilation of the brachial artery----[1] 49
261FLT190----[1] 19
262Flu-ATG----[1] 60
263Flucinolone acetonide----[1] 56
264FLUCLOXACILLIN[1] Flucloxacillin[3] D01249 ,
D04196 ,
D07965 		--[1] 299
265Flucloxacillin 250mg/5ml Sugar-Free Powder for Oral Solution[1] Flucloxacillin[3] D01249 ,
D04196 ,
D07965 		--[1] 299
266FLUCLOXACILLIN SODIUM[1] Flucloxacillin[3] D01249 ,
D04196 ,
D07965 		--[1] 299
267Flucloxicillin----[1] 299
268FLUCONAZOLE[1] Fluconazole[2] D00322 ,
D01429 		--[2] 96, 225
269FLUDARA[1] Fludarabine[2] D01907 ,
D07966 		[1] RRM1 💬[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬[1] 13
270Fludarabina[1] Fludarabine[2] D01907 ,
D07966 		[1] RRM1 💬[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬[2] 19, 65
271Fludarabina Accord[1] Fludarabine[2] D01907 ,
D07966 		[1] RRM1 💬[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬[1] 65
272FLUDARABINA ACCORD - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 5 FLACONCINI IN VETRO DA 2 ML[1] Fludarabine[2] D01907 ,
D07966 		[1] RRM1 💬[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬[1] 19
273FLUDARABINA FOSFATO[1] Fludarabine[2] D01907 ,
D07966 		[1] RRM1 💬[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬[1] 19
274FLUDARABINA TEVA - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 1 FLACONCINO DI VETRO DA 2 ML[1] Fludarabine[2] D01907 ,
D07966 		[1] RRM1 💬[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬[1] 65
275Fludarabine[1] Fludarabine[2] D01907 ,
D07966 		[1] RRM1 💬[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬[18] 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326
276Fludarabine (FLU)[1] Fludarabine[2] D01907 ,
D07966 		[1] RRM1 💬[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬[2] 60, 285
277Fludarabine monophosphate[1] Fludarabine[2] D01907 ,
D07966 		[1] RRM1 💬[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬[3] 65, 284, 326
278Fludarabine phosphate[2] Fludarabine,
Phosphate ion		[2] D01907 ,
D07966 		[1] RRM1 💬[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬[12] 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286
279Fludarabine phosphate 30 mg[2] Fludarabine,
Phosphate ion		[2] D01907 ,
D07966 		[1] RRM1 💬[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬[2] 65, 164
280Fludarabine phosphate 40 mg[2] Fludarabine,
Phosphate ion		[2] D01907 ,
D07966 		[1] RRM1 💬[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬[2] 65, 164
281Fludarabine, Busulfan, Thymoglobulin[3] Antithymocyte immunoglobulin (rabbit),
Busulfan,
Fludarabine		[3] D00248 ,
D01907 ,
D07966 		[1] RRM1 💬[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬[1] 65
282Fludarabine, Cyclophosphamide[2] Cyclophosphamide,
Fludarabine		[4] D00287 ,
D01907 ,
D07760 ,
D07966 		[1] RRM1 💬[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬[1] 60
283Fludarabine, Melphalan, Thiotepa[3] Fludarabine,
Melphalan,
Thiotepa		[4] D00369 ,
D00583 ,
D01907 ,
D07966 		[1] RRM1 💬[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬[1] 65
284Fludarabine/ melphalan[2] Fludarabine,
Melphalan		[3] D00369 ,
D01907 ,
D07966 		[1] RRM1 💬[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬[1] 60
285Fludarabine/busulfan[2] Busulfan,
Fludarabine		[3] D00248 ,
D01907 ,
D07966 		[1] RRM1 💬[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬[1] 60
286Fludeoxyglucose[1] Fludeoxyglucose (18F)---[4] 34, 84, 85, 88
287Fludeoxyglucose F 18[2] Fludeoxyglucose,
Fludeoxyglucose (18F)		[1] D01843 --[1] 34
288Fludrocortisone[1] Fludrocortisone[2] D00986 ,
D07967 		[1] NR3C2 💬[1] Aldosterone-regulated sodium reabsorption 💬[3] 6, 17, 81
289Fluimucil----[4] 85, 94, 193, 298
290Fluimucil (acetylcysteine)[1] Acetylcysteine[1] D00221 --[1] 193
291FLUIMUCIL*20CPR EFF 600MG----[2] 94, 298
292Fluimucil® 600 mg effervescent tablets----[1] 85
293Flumazenil[1] Flumazenil[1] D00697 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[5] 6, 13, 17, 18, 206
294FluMist[1] Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen---[1] 299
295Flumist®[1] Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen---[1] 299
296Fluocinolone[1] Fluocinolone---[1] 90
297Fluocinolone Acetonide[2] Fluocinolone,
Fluocinolone acetonide		[1] D01825 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 90
298Fluorescein[1] Fluorescein[2] D01261 ,
D02024 		--[3] 19, 22, 97
299Fluorescence endoscopy and spectroscopy----[1] 96
300Fluorescence Imaging----[1] 46
301Fluorescite----[1] 215
302FLUORINE (18F) FLUDEOXYGLUCOSE[1] Fludeoxyglucose[1] D01843 --[2] 84, 85
303FLUORINE-18[1] Fluorine F-18[1] D05860 --[1] 41
304Fluorodeoxyglucose----[1] 84
305Fluoroscopic swallow evaluation----[1] 6
306Fluoxetin[1] Fluoxetine[2] D00326 ,
D00823 		[1] SLC6A4 💬[2] Serotonergic synapse, Synaptic vesicle cycle 💬[3] 13, 179, 206
307Fluoxetin Hexal[1] Fluoxetine[2] D00326 ,
D00823 		[1] SLC6A4 💬[2] Serotonergic synapse, Synaptic vesicle cycle 💬[1] 13
308FLUOXETINE[1] Fluoxetine[2] D00326 ,
D00823 		[1] SLC6A4 💬[2] Serotonergic synapse, Synaptic vesicle cycle 💬[4] 13, 17, 78, 86
309FLUOXETINE HYDROCHLORIDE[1] Fluoxetine[2] D00326 ,
D00823 		[1] SLC6A4 💬[2] Serotonergic synapse, Synaptic vesicle cycle 💬[1] 13
310Fluoxétine[1] Fluoxetine[2] D00326 ,
D00823 		[1] SLC6A4 💬[2] Serotonergic synapse, Synaptic vesicle cycle 💬[1] 17
311Flupentixol[1] Flupentixol[1] D01044 [2] DRD1,
DRD2 💬		[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 97
312Flupirtin----[1] 13
313Flupirtine[1] Flupirtine[1] D07978 --[1] 13
314Flupirtinmaleat----[1] 13
315FLURBIPROFEN[1] Flurbiprofen[3] D00330 ,
D01475 ,
D02290 		[2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[3] 13, 21, 46
316Flutamide[1] Flutamide[1] D00586 [1] AR 💬[4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬[1] 81
317Flutemetamol[1] Flutemetamol (18F)---[5] 5, 6, 7, 17, 127
318Flutemetamol F18[2] Flutemetamol,
Flutemetamol (18F)		---[5] 5, 6, 7, 17, 127
319Fluticasone[1] Fluticasone[1] D07981 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 98, 228, 299
320Fluticasone MDI[1] Fluticasone[1] D07981 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
321FLUTICASONE PROPIONATE[1] Fluticasone propionate[1] D01708 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 98, 228
322Fluticasone Propionate, 800 mcg twice daily (post 4FED failure)[1] Fluticasone propionate[1] D01708 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
323Fluticasone Propionate, 880 mcg twice daily (after 6FED failure)[1] Fluticasone propionate[1] D01708 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
324Fluticasone Propionate, USP[1] Fluticasone propionate[1] D01708 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
325Fluvastatin[1] Fluvastatin[2] D00892 ,
D07983 		[1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[3] 79, 218, 222
326Fluzone[1] Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated)---[2] 21, 49
327Fluzone®[1] Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated)---[1] 21
328FLX-787-ODT----[1] 2
329FLX-787-ODT (orally disintegrating tablet)----[1] 10
330FLX-787-ODT (orally disintigrating tablet)----[1] 2
331FMP-30----[1] 53
332FMP30 Donor Stool----[1] 13
333FMT----[2] 96, 97
334FMT enema----[1] 97
335FMT infusions----[1] 97
336FMT oral----[1] 97
337FMT+MTX----[1] 46
338Focetria----[1] 46
339Focetria (Monovalent MF59-Adjuvanted vaccine)----[3] 46, 49, 271
340Folate[1] Folic acid[1] D00070 --[4] 13, 41, 46, 49
341FolateScan (Technetium Tc 99mEC20)----[4] 13, 46, 49, 96
342Folic (or folinic) acid----[2] 46, 256
343Folic acid[1] Folic acid[1] D00070 --[4] 6, 46, 49, 84
344Folic acid or folate[1] Folic acid[1] D00070 --[1] 46
345Folic Acid, Vitamin B6, Vitamin B12[3] Cyanocobalamin,
Folic acid,
Pyridoxine		[7] D00070 ,
D00166 ,
D02179 ,
D03615 ,
D03616 ,
D03617 ,
D08454 		--[1] 6
346Folic/folinic acid[1] Leucovorin[3] D01211 ,
D07986 ,
D07987 		--[2] 46, 107
347Foliglurax[1] Foliglurax---[1] 6
348Foliglurax 10 mg (treatment A)[1] Foliglurax---[1] 6
349Foliglurax 30 mg (treatment B)[1] Foliglurax---[1] 6
350Folimet----[1] 46
351Folinic acid[1] Leucovorin[3] D01211 ,
D07986 ,
D07987 		--[3] 46, 107, 320
352Follow-up probiotic----[1] 193
353Follow-up study of the treated cohort----[1] 193
354Fontolizumab[1] Fontolizumab[1] D04242 [1] IFNG 💬[32] African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 46
355Foralumab[1] Foralumab---[2] 13, 96
356Forigerimod[1] Forigerimod[1] D09904 --[1] 49
357FORLAX 4 g, poudre pour solution buvable en sachet----[1] 299
358Formalin[1] Formaldehyde[1] D00017 --[1] 84
359Formistin----[1] 13
360FORMISTIN - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE----[1] 13
361Formistin 10 mg----[1] 13
362Formoterol[1] Formoterol[3] D01373 ,
D05277 ,
D07990 		[1] ADRB2 💬[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[3] 85, 228, 299
363Formoterol fumarate dihydrate[1] Formoterol[3] D01373 ,
D05277 ,
D07990 		[1] ADRB2 💬[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 85
364Formoterol/Budesonide[2] Budesonide,
Formoterol		[4] D00246 ,
D01373 ,
D05277 ,
D07990 		[2] ADRB2,
NR3C1 💬		[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 228
365Formulation A----[1] 13
366Formulation B----[1] 13
367Formulation C----[1] 13
368Formulation D----[1] 13
369Forsteo[1] Teriparatide[1] D06078 [1] PTH1R 💬[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[3] 70, 235, 274
370FORSTEO-R[1] Teriparatide[1] D06078 [1] PTH1R 💬[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235
371FORTECORTIN----[2] 28, 65
372Fortecortin Inject 40 mg Amp.----[1] 65
373Forteo[1] Teriparatide[1] D06078 [1] PTH1R 💬[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 70
374Fortum----[1] 299
375FOS----[2] 66, 96
376Foscarbidopa[1] Foscarbidopa[1] D12057 --[1] 6
377Foscarbidopa and Foslevodopa[2] Foscarbidopa,
Foslevodopa		[2] D11839 ,
D12057 		[5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
378Foscarnet[1] Foscarnet[2] D00579 ,
D02267 		--[2] 28, 60
379Foscarnet sodium[1] Foscarnet[2] D00579 ,
D02267 		--[2] 28, 60
380FosD----[1] 46
381Fosfamatinib Disodium----[1] 46
382Fosfato sodico de dexametasona[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 96
383Fosfomycin[1] Fosfomycin[4] D00925 ,
D02187 ,
D02188 ,
D04253 		--[2] 96, 97
384FOSFOMYCIN DISODIUM[1] Fosfomycin[4] D00925 ,
D02187 ,
D02188 ,
D04253 		--[1] 97
385Foslevodopa[1] Foslevodopa[1] D11839 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
386Fosmetpantotenate----[1] 120
387Fosmetpantotenate (RE-024)----[1] 120
388FOSMETPANTOTENATE DRUG SUBSTANCE----[1] 120
389Fosmetpantotenato----[1] 120
390Fospropofol[1] Fospropofol---[1] 226
391Fospropofol (Lusedra®) 10[1] Fospropofol---[1] 226
392Fospropofol (Lusedra®) 12[1] Fospropofol---[1] 226
393Fospropofol (Lusedra®) 6.5[1] Fospropofol---[1] 226
394Fostair----[1] 85
395Fostamatinib[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[4] 46, 49, 61, 66
396Fostamatinib 100 mg[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[1] 66
397Fostamatinib 100 mg tablet[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[1] 66
398Fostamatinib 150 mg[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[1] 66
399Fostamatinib 150 mg bid[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[1] 61
400Fostamatinib 150 mg tablet[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[1] 66
401Fostamatinib 50 mg blue film-coated tablet[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[1] 46
402Fostamatinib Disodium[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[3] 46, 61, 66
403Fostamatinib Disodium (R935788)[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[2] 46, 49
404Fostamatinib Disodium tablet 100 mg[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[1] 66
405Fostamatinib Disodium tablet 150 mg[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[1] 66
406Four-point cane (FPC)----[1] 13
407Fourier Domain Doppler Optical Coherence Tomography (FDOCT)----[1] 13
408FP-045----[1] 285
409FP-110----[1] 97
410FP-CYA-050----[1] 97
411FP-CYA-053----[1] 97
412FPA008----[1] 46
413FPC----[1] 13
414FPF 300 (thalidomide)[1] Thalidomide[1] D00754 [1] TNF 💬[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 16
415FPF1011----[1] 263
416FPF1100NW----[1] 6
417FPFS-1169----[1] 6
418FR104----[1] 46
419Fractional carbon dioxide laser[2] Activated charcoal,
Carbon dioxide		[1] D00004 --[1] 51
420Fractionated Carbon Dioxide (FCO2) Laser[2] Activated charcoal,
Carbon dioxide		[1] D00004 --[1] 50
421Fragmin[1] Dalteparin---[1] 222
422Free amino acids intake[1] Amino acids---[1] 240
423Freeze-dried black raspberry powder[1] Raspberry[1] D09179 --[1] 97
424Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS)[1] Human immunoglobulin G---[3] 14, 43, 45
425Fremanezumab[1] Fremanezumab[1] D11055 [1] CALCA 💬[2] Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬[2] 124, 226
426Frequently Sampled Oral Glucose Tolerance Test and CGM[1] Dextrose, unspecified form---[1] 299
427Fresenius-Kabi)----[1] 46
428Fresh Frozen Plasma----[1] 5
429Fresolimumab[1] Fresolimumab[1] D09620 [3] TGFB1,
TGFB2,
TGFB3 💬		[35] AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬[3] 51, 222, 274
430Frisium----[1] 140
431FRISIUM*30CPS 10MG----[1] 140
432FRM-0334----[1] 127
433From August 2020 'no additional treatment'----[1] 51
434FSME-IMMUN----[1] 46
435FT011----[1] 51
436FT011 100 mg----[1] 51
437FT011 200 mg----[1] 51
438FTI, AZLI----[1] 299
439FTX-1821----[1] 113
440FTY720----[2] 13, 14
441FTY720D----[1] 13
442FTY720I----[1] 14
443Fucidin[1] Fusidic acid[1] D04281 --[1] 299
444Fucidin Tablets[1] Fusidic acid[1] D04281 --[1] 299
445Fucose[1] Fucose---[1] 65
446Full Spectrum vitamin----[1] 13
447Fully human anti-interferon gamma monoclonal antibody[1] Interferon Gamma---[1] 107
448Fully human IgG2 lambda monoclonal antibody----[1] 172
449Fully human monoclonal antibody directed against CXCL10----[1] 93
450Fully humanised, recombinant monoclonal antibody (IgG1)----[1] 96
451Fully humanized anti-human IL-6 receptor (IL-6R) neutralizing monoclonal antibody----[1] 13
452Fultium-D3 800IU capsules----[1] 274
453Fulvestrant[1] Fulvestrant[1] D01161 [2] ESR1,
ESR2 💬		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 86
454Fumaderm----[1] 49
455Fumaderm®----[1] 49
456Fumaderm® initial----[1] 49
457Fumaric acid[1] Fumaric acid[1] D02308 --[1] 13
458Functional hepatic nitrogen clearance[1] Nitrogen[1] D00083 --[1] 171
459Functional Magnetic Resonance Imaging----[1] 6
460FURESTEM-RA Inj----[1] 46
461FURESTEM-RA Inj.----[1] 46
462Furosemide[1] Furosemide[1] D00331 [1] SLC12A2 💬[3] Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬[1] 6
463Furosemide Injection[1] Furosemide[1] D00331 [1] SLC12A2 💬[3] Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬[1] 6
464FUSIDIC ACID[1] Fusidic acid[1] D04281 --[1] 299
465Fusidin----[1] 299
466Fusion[1] Iron polymaltose---[7] 11, 13, 46, 49, 69, 70, 271
467Fuzhenghuayu----[1] 93
468Fx-1006A[1] Fx-1006A---[1] 28
469FX125L----[1] 46
470FXIII Concentrate (Human)----[1] 288
471FXIII Concentrate (Human) (FXIII)----[1] 288
472Fycompa[1] Perampanel[1] D08964 [4] GRIA1,
GRIA2,
GRIA3,
GRIA4 💬		[16] Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬[2] 2, 144